Corrigendum to “Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson’s disease” [Cell. Immunol. 327 (2018) 77–82]
作者
Marina N. Karpenko,А. А. Василишина,Е. А. Громова,Zamira Muruzheva,Alexandra Bernadotte